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Abstract 
The output from protein biomanufacturing systems is a function of total host cell biomass synthetic 
capacity and recombinant protein production per unit cell biomass. In this study we describe how 
these two properties can be simultaneously optimized via design of a product-specific combination 
of synthetic DNA parts to maximize flux through the protein synthetic pathway and the use of a 
host cell chassis with an increased capability to synthesise both cell and product biomass. Using 
secreted alkaline phosphatase (SEAP) production in Chinese hamster ovary cells as our example, 
we demonstrate how an optimal composition of input components can be assembled from a 
minimal toolbox containing rationally designed promoters, untranslated regions, signal peptides, 
product coding sequences, cell chassis and genetic effectors. Product titer was increased 10-fold, 
compared to a standard reference system by i) identifying genetic components that acted in concert 
to maximize the rates of SEAP transcription, translation and translocation, ii) selection of a cell 
FKDVVLV ZLWK LQFUHDVHG ELRPDVV V\QWKHWLF FDSDFLW\ DQG LLL HQJLQHHULQJ WKH KRVW FHOO IDFWRU\¶V
capacity for protein folding and secretion. This whole synthetic pathway engineering process to 
design optimal expression cassette-chassis combinations should be applicable to diverse 
recombinant protein and host cell type contexts. 
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Introduction 
Synthetic biology promises to revolutionize biotechnology by enabling the rational design of 
genetic constructs (parts) and cells (chassis) with predictable user-defined functions. It is 
particularly applicable to recombinant protein manufacturing, where the engineered system 
comprises just two key biological components, a recombinant gene expression cassette and a host-
cell factory, and two critical system outputs, product yield and quality. Although diverse eukaryotic 
and prokaryotic cell-types are used to produce recombinant proteins, the core biomanufacturing 
process remains constant. A cell factory must create and maintain cellular biosynthetic capacity, 
and utilize it to synthesize a complex protein product. As shown in Figure 1, product yields are a 
function of the rates of five key biosynthetic steps (four if product membrane translocation is not 
required), each of which can be controlled by re-design of either the cell chassis or a discrete genetic 
component. Strategies to enhance product yield have traditionally been limited to increasing the 
output from a single one of these steps, typically resulting in relatively modest improvements (Davy 
et al., 2017; Wells & Robinson, 2017; Xiao et al., 2014). Given recent advances in DNA-part and 
chassis engineering, we should be able to move beyond modulation of individual cellular processes, 
and create a new paradigm for biomanufacturing where the entire product biosynthetic pathway is 
specifically designed to maximize system output.  
Designing an optimal chassis-expression cassette combination is complicated by the fact 
that the quantitative output of synthetic genetic constructs (e.g. the amount of mRNA transcribed) 
can be inversely correlated with host cell factory performance characteristics (Ceroni et al., 2015; 
Gorochowski et al., 2016; Scott et al., 2010). Heterologous protein expression imposes a metabolic 
load on the host cell, requiring consumption of limited cellular resources, such as polymerases, 
ribosomes and protein folding chaperones (Borkowski et al., 2016; Raveh et al., 2016; Weiße et 
al., 2015). Any attempt to increase the flux through a step in the product biosynthetic pathway via 
DNA-part design, for example by utilizing a stronger promoter, exerts a concomitant increase in 
chassis burden. This can be manifested as a reduction in cell growth, an increase in cell stress/death, 
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and the induction of bottlenecks in the recombinant protein synthetic pathway, particularly in 
protein folding and secretion (Delic et al., 2014; Dong et al., 1995; Hoffmann & Rinas, 2004). 
Accordingly, it is challenging to create ideal biomanufacturing systems where total cell biomass, 
and protein production per unit cell biomass, are both maximized. 
Efforts to optimize the chassis-expression cassette interactome (all direct and indirect 
interactions between the host cell and rDNA or rDNA-derived synthetic intermediates) have 
focused on reducing the burden that synthetic constructs impose on the host cell. For example, 
using inducible expression systems, product biosynthesLVFDQEHVHOHFWLYHO\µWXUQHG-RII¶GXULQJWKH
early stages of culture to facilitate maximized accumulation of cellular capacity (Møller et al., 2017; 
Shrestha & Hildebrand, 2017). The overall biosynthetic cost of recombinant protein production 
may also be reduced by the use of orthogonal transcriptional/ translational machineries, where the 
associated metabolic load is preferable to the over-consumption of particularly limited cellular 
resources %HUYRHWVHWDO'H-RQJHWDO6HJDOOဨ6KDSLURHt al., 2014). Further, negative 
feedback loops containing stress-responsive promoters can be designed to automatically tune 
product expression levels down when burden causes deleterious effects to chassis performance 
(Ceroni et al., 2018; Dragosits et al., 2012). While these approaches enable improvements in overall 
system output, they typically increase cell biomass creation and maintenance at the expense of flux 
through the product biosynthetic pathway. Accordingly, expression cassette design, and therefore 
product yields, are constrained by the limitations of the chassis. Although cell factory capacities 
can be increased via genetic engineering, the performance of the designed chassis tends to be highly 
context-specific, dependent on the product, cell strain, expression cassette, and production process 
(Delic et al., 2014; Fischer et al., 2015; Hansen et al., 2017; Waegeman & Soetaert, 2011). We 
therefore hypothesized that in order to create an ideal biomanufacturing system the expression 
cassette should first be designed to maximize flux through product gene transcription, mRNA 
translation and protein translocation, before the chassis is subsequently specifically optimized to 
handle the associated metabolic load. While context-dependency and incomplete understanding of 
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cell factory and DNA-part functionalities prevents forward engineering of such systems (Cardinale 
& Arkin, 2012; Pasotti & Zucca, 2014), we reasoned that for a given product, an optimal 
combination of synthetic elements, each controlling a discrete step in the synthetic pathway (e.g. 
promoters, untranslated regions, signal peptides, product coding sequences, chassis and protein 
folding enhancers) could be identified by rational screening of a minimal toolbox of components. 
Here, using Secreted alkaline phosphatase production in Chinese Hamster Ovary cells as our 
example, we show that i) application of this approach enables simultaneous maximization of both 
cellular biomass capacity and cell specific productivity, and ii) synthetic manipulation of the entire 
product biosynthetic pathway results in substantially greater recombinant protein yields than 
engineering the cell or DNA parts in isolation. In doing so, we illustrate a process for designing 
optimal chassis-expression cassette combinations that should be applicable to diverse product-host 
cell type bioproduction contexts. 
 
Materials and methods 
Synthetic part design 
Promoters: To generate 100RPU_PH, the proximal promoter region of 100RPU.2 (GenBank 
accession number (GAN) LC270637, nucleotides 1 -  ZDV DGGHG WR WKH ¶ WHUPLQXV RI
100RPU.1 (GAN LC270636). To create 100RPU.1_SC2, 100RPU.1_SC3, and 100RPU.1_SC4, 
the proximal promoter region of 100RPU.1 (nucleotides 1 ± 209) was fused to super core promoter 
2 (Juven-Gershon et al., 2006), 3 (Even et al., 2016) and 4 (a hCMV-IE1 core promoter modified 
to contain DCE (D.-H. Lee et al., 2005) and DTIE (Marbach-Bar et al., 2015) elements) 
respectively. The transcription factor binding site, and core promoter element, composition of each 
synthetic promoter is shown in Supplementary Figure 1. Sequences have been deposited with the 
DNA Data Bank of Japan (accession numbers LC380022 ± LC380025). 
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Protein coding sequences: 7R JHQHUDWH 6($3B02 WKH µQDWLYH¶ VHFUHted alkaline 
phosphatase (SEAP) coding sequence (signal peptide + mature protein coding sequence; GAN 
U89938.1, nucleotides 272 ± 1831) was re-designed for expression in Chinese hamster ovary 
&+2FHOOVXVLQJWKH*HQH2SWLPL]HUDOJRULWKP(Raab et al., 2010). SEAP_CAI and SEAP_HT 
were created using the Codon Optimization On-Line (COOL) software tool (Chin et al., 2014), 
DFFRUGLQJWRWKHIROORZLQJUHVSHFWLYHGHVLJQVHWWLQJVLPD[LPL]DWLRQRIWKHVHTXHQFH¶VFRGRQ
adaption index value, and ii) maximizatioQRIµIROGLQJLQVWDELOLW\¶DQGFRGRQFRQWH[WVFRUHEHWZHHQ
nucleotides 1 ± 50 and 51 ± 1560 respectively. Finally, SEAP_MSS was designed using EuGene 
(Gaspar et al., 2012), employing minimization of secondary structure free energy as the sole design 
parameter. Synthetic gene sequences were analyzed to check for the presence of splice sites 
(NNsplice (Reese et al., 1997); detection threshold = 0.6), transcription termination motifs 
(AATAAA; 100% match), transcription initiation motifs (MatInspector (Cartharius et al., 2005) 
matrix library = general core promoter elements, core/ matrix similarity threshold = 1.00/ 0.95), 
and mRNA instability elements (ATTTA, GTTTG, TTTTT, TTTGTTT, TTTTAAA; 100% match). 
Undesirable sequence features were removed by substituting an appropriate codon, where all 
possible codon-replacement solutions were tested to identify those that had minimal impact on 
desired design criteria. Sequences have been deposited with the DNA Data Bank of Japan 
(accession numbers LC380026 ± LC380029).  
Signal peptides: 1313 experimentally-verified mammalian (human and murine) signal 
peptide sequences were extracted from the Signal Peptide Website (www.signalpeptide.de). 
Examination of these sequences revealed that the majority of constructs (717) were between 18 and 
24 amino acids (aa) in length. Signal peptides in this size range were analyzed to determine the 
modal length and amino acid usage bias of constituent N-terminal, Hydrophobic, and C-terminal 
regions (see Fig. S2). Using this information, thousands of synthetic subcomponents were 
randomly generated according to the following design rules: N-terminal regions -  length = 4 aa, 
composite aa = A, G, K, L, M (only in position one), P, R, S; Hydrophobic regions ± length = 13 
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aa, composite aa = A, L, V; C-terminal regions ± length = 5 aa, composite aa = A, G, L, P, S. These 
sub-SDUWV DQG WKRVH IURP WKH SUHYLRXVO\ GHVFULEHG µVXSHU¶ V\QWKHWLF VLJQDO SHSWLGH 6HFUHFRQ
(Barash et al., 2002) were then randomly combined to create 10,000, 21-aa-long novel components 
)LJ67RGHWHUPLQHSUHGLFWHGFOHDYDJHVLWHVDQGUHODWLYH³VLJQDOSHSWLGH-QHVV´'-scores), each 
synthetic signal peptide was screened in silico using SignalP 4.1 (www.cbs.dtu.dk/services/SignalP 
(Petersen et al., 2011)). The four components with the highest D-score values were selected for in 
vitro testing, alongside secrecon. Güler-Gane et al. recently showed that the secretion efficiency of 
recombinaint proteins can be generally increased by inserting two alanine residues at the signal 
peptide-mature protein junction (Güler-Gane et al., 2016), and accordingly this design feature was 
added to all five synthetic components (see Table S1 for sequences).  
Expression cassette construction 
A standard reference expression cassette was designed to contain the following components: 
hCMV-IE1 promoter (GAN M60321.1, nucleotides 517 ± 1193); hCMV-,( ¶ 875 *$1
M60321.1, nucleotides 1194 - 2103 µSHUIHFW¶ NR]DN FRQsensus sequence (GCCACC); native 
SEAP signal peptide (GAN U89938.1, nucleotides 272 - 323); native mature SEAP coding 
sequence (GAN U89938.1, nucleotides 324 - DQGDQ69¶875*$1/7
nucleotides 1449 ± 1676). This construct was synthesized and cloned into the pMA vector 
(GeneArt, Regensburg, Germany) to create pMA-SRS. Designed synthetic parts, and combinations 
thereof, were synthesized and inserted into pMA-SRS, replacing corresponding standard reference 
components. Note that i) when synthetic signal peptides were tested in isolation, GeneOptimizer 
ZDVXWLOL]HGWRJHQHUDWHVLJQDOSHSWLGHFRGLQJVHTXHQFHVWKDWZHUHLQVHUWHGGLUHFWO\XSVWUHDPRI
the native mature SEAP coding sequence, and ii) when gene optimization methods were applied, 
the entire protein coding sequence (i.e. signal peptide + mature SEAP coding sequence) was re-
designed. 
Construction of effector gene expression plasmids 
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Cypb (UniProt accession number (UAN P23284), Ero1a (UAN Q96HE7), Pdia1 (UAN P07237), 
Pdia4 (UAN P13667), Bip (UAN P11021), Calr (UAN P27797), Canx (UAN P27824), Hspa1a 
(UAN P0DMV8), Tor1a (UAN O14656), Atf6ac (UAN P18850, amino acids 1 - 377), Xbp1s (UAN 
P17861, isoform 2) and Cert (UAN Q9Y5P4) protein coding sequences were optimized for 
expression in CHO FHOOV XVLQJ *HQH2SWLPL]HU  V\QWKHVL]HG DQG LQVHUWHG LQWR S0$-SRS, 
replacing the native SEAP signal peptide and mature protein coding sequence. Constitutively active 
versions of transactivators were utilized, corresponding to 50 kDa and 54 kDa forms of ATF6A 
(ATF6Ac) and XBP1 (XBP1s) respectively.  
CHO cell culture 
CHO-S_C1.80 (evolved chassis (ECH) 1), CHO-S_C2.200 (ECH2), CHO-S_C4.200 (ECH3), 
CHO-S_C11.80 (ECH4) and CHO-S_C17.200 (ECH5) were obtained from A. Fernandez-Martell 
)HUQDQGH]ဨ0DUWHOO HW DO 2018). These cell lines, and standard CHO-S cells (Thermo Fisher 
Scientific, Paisley, UK), were routinely cultured in CD-CHO medium (Thermo Fisher Scientific) 
at 37°C in 5% (v/v) CO2 in vented Erlenmeyer flasks (Corning, UK), shaking at 140 rpm, and 
subcultured every 3-4 days at a seeding density of 2 x 105 cells/ml. Cell concentration and viability 
were determined by an automated Trypan Blue exclusion assay using a Vi-Cell cell viability 
analyser (Beckman-Coulter, High Wycombe, UK). 
Characterizing the performance of discrete expression cassette-chassis combinations 
A high-throughput component-palette screening platform was optimized, with respect to DNA 
load, Lipofectamine concentration and cell seeding density, to facilitate maximal SEAP production 
titers. Specifically, 8 x 105 cells from a mid-exponential phase culture were seeded into individual 
wells of a 24 well plate (Nunc, Stafford, UK), and subsequently transfected with DNA-lipid 
complexes comprising 500 ng of DNA and 3 µl of Lipofectamine (Thermo Fisher Scientific). 
Transfected cells were incubated for 72 h prior to quantification of SEAP protein expression using 
the Sensolyte pNPP SEAP colorimetric reporter gene assay kit (Cambridge Biosciences, 
Cambridge, UK). Total cellular capacity (integral of viable cell concentration) and cell specific 
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productivity (qP) were calculated as described by Khoo and Al-Rubeai (cell growth was measured 
at 24 h intervals; .KRR	$Oဨ5XEHDL 
Fed-batch transient transfection 
Two hours prior to transfection 7 x 106 cells from mid-exponential phase CHO cell cultures were 
seeded into 50 mL CultiFlask bioreactors (Sartorius, Surrey, UK) at a working volume of 10 ml. 
Cells were transfected with DNA-lipid complexes, comprising 40 µg of DNA and 160 µl of 
Lipofectamine. To prevent cell clumping, 36 µl of Anti-Clumping Agent (Thermo Fisher 
Scientific) was added 24 hr post transfection. Fed-batch cultures were maintained for six days by 
nutrient supplementation with 10% v/v CHO CD Efficient Feed B (Thermo Fisher Scientific) on 
day 0, 1, 4 and 5. Cell viabilities were measured on day 4 and 5 to confirm that they had not dropped 
below 70%. 
 
Results and discussion 
Creating a minimal synthetic component design-palette to maximize recombinant protein 
yield 
Forward engineering of protein biomanufacturing systems is restricted by the context-dependent 
function of genetic constructs and cell factories (Cardinale & Arkin, 2012; Nikel et al., 2014; 
Pasotti & Zucca, 2014). Accordingly, to assemble an expression cassette-cell combination which 
maximizes flux through each step in product biosynthesis, component libraries must first be tested 
to identify parts and chassis with desired functionalities. However, given that i) well-characterized 
parts and chassis are available for all commonly-utilized bioproduction hosts, and ii) it is relatively 
simple to create novel components with user-defined functions, it should be possible to rapidly 
perform such screens using minimal design-palettes. While some part types and design methods 
may vary depending on the specific protein-cell type combination, the design-test-build process 
that we present here will be generally applicable in all biomanufacturing contexts. To demonstrate 
the power of this approach we created a component-palette to maximize SEAP (a human 
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glycoprotein) production in Chinese hamster ovary (CHO) cells, the predominant 
biopharmaceutical expression host (Fig. 2). 
Gene transcription. Context-specific maximization of recombinant gene transcription 
requires identification of an appropriate promoter part. As highly active promoters have been 
created for use in all bioproduction hosts, a component with the required functionality can be 
simply selected by screening a small panel (e.g. < 10) of previously characterized synthetic 
constructs (Brown & James, 2015; Gilman & Love, 2016; Redden et al., 2014). Alternatively, a 
µJROGVWDQGDUG¶SDUWFDQEHXVHGGLUHFWO\LILWKDVEHHQVSHFLILFDOO\GHVLJQHGVKRZQWRPD[LPL]H
transcriptional output in diverse expression conditions. A component with this functionality has 
reportedly been constructed for use in CHO cells. Synthetic promoter 100RPU.1 was specifically 
designed in silico, using transcription factor binding sites (TFBSs) with requisite functionalities, to 
exhibit maximal transcriptional activity and long-term expression stability, without imposing off-
target effects on CHO cell growth or viability (Brown et al., 2017).  However, this construct was 
not explicitly shown to exhibit the highest promoter activity possible in CHO cells. Accordingly, 
we included this part in our component-palette, but also rationally designed four 100RPU.1-
variants to test if transcriptional output could be further increased (Fig. S1). We hypothesized that 
the output from 100RPU.1 could be enhanced by either increasing the number of TFBSs in the 
proximal region (limited to 14 in the original design), or replacing the non-engineered minimal 
core region (taken from the hCMV-IE1 promoter). We therefore i) constructed a hybrid promoter 
(100RPU_PH) containing the proximal regions from both 100RPU.1 and a second highly active 
synthetic part, 100RPU.2 (Brown et al., 2017), and ii) created elements (100RPU.1_SC2, 
100RPU.1_SC3, 100RPU.1_SC4) where the hCMV-IE1 core promoter was substituted by varying 
µVXSHUFRUHV¶WKDWDUHVSHFLILFDOO\GHVLJQHGWRPD[LPL]HWUDQVFULSWLRQLQLWLDWLRQUDWHV(Even et al., 
2016; Juven-Gershon et al., 2006) (see Fig. S1). 
mRNA translation. Translational output, a function of mRNA stability and translation 
initiation/ elongatLRQ UDWHV LVGHWHUPLQHGFROOHFWLYHO\E\ WKHSURWHLQFRGLQJ VHTXHQFHDQG¶/3¶ 
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XQWUDQVODWHGUHJLRQV8757KHIXQFWLRQRINH\¶875HOHPHQWVFRQWUROOLQJWUDQVODWLRQLQLWLDWLRQ
(e.g. Shine-Dalgarno sequences in prokaryotes, Kozak sequences in eukaryotes) is well understood 
and can be predictably controlled (Kozak, 1987; Reeve et al., 2014). However, relatively little is 
known about how other UTR sequence features affect mRNA half-life and translation rate. It is 
therefore difficult to rationally select or design UTR-parts that are fully optimized for a specific 
context or purpose. Accordingly, we rationalized that for these components we would instead have 
to utilize existing constructs that are known to exhibit desirable functionality. For this example, we 
employed parts that are commonly used in high-producing CHO cell biomanufacturing systems, 
the 69¶875DQGDK&09-,(¶875WKDWKDVEHHQPRGLILHGWRFRQWDLQDµSHUIHFW¶.R]DN
consensus sequence (hCMV-IE1+PKS). 
Design principles governing protein coding sequence performance are similarly poorly 
understood. While many critical mRNA sequence features have been identified, including codon 
context, local/ global secondary structure, instability motifs and GC content, multivariate 
optimization of these interdependent parameters to maximize translational output is currently 
intractable (Gould et al., 2014; Parret et al., 2016). However, unlike UTRs, a tried and tested 
FRPSRQHQW FDQQRW EH XVHG µRII WKH VKHOI¶ DV QHZ FRQVWUXFWV PXVW EH generated for each novel 
product. While it is not possible to rationally build optimal protein coding sequences, we reasoned 
that a component exhibiting near-maximal translational output could be identified by testing 
multiple parts optimized according to divergent design rules. Here, we created synthetic constructs 
with varying characteristics using four distinct design methods that have previously been shown to 
increase protein expression levels when compared to non-optimized native sequences. Specifically, 
we employed the following design strategies: i) minimization of mRNA secondary structures (i.e. 
PD[LPL]LQJ WKH FRQVWUXFW¶V PLQLPXP IUHH HQHUJ\ 6($3B066 (Kim et al., 2010), ii) codon 
optimization according to usage bias in the host cell-type (i.e. maxiPL]LQJ WKH JHQH¶V FRGRQ
adaptation index value; SEAP_CAI) (Gustafsson et al., 2004), iii) multiparameter optimization of 
codon usage, secondary structure and GC-content using a sliding window approach (SEAP_MO) 
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(Fath et al., 2011), and iv) independent engineering of the mRNA head and tail sections to minimize 
secondary structure and optimize codon context (i.e. match the codon pair usage pattern of host 
cell genes) respectively (SEAP_HT) (B. K.-S. Chung et al., 2013; Kudla et al., 2009). In each case 
the formation of undesirable sequence features known to negatively affect component performance, 
such as splice sites and mRNA instability elements, were specifically precluded (Gould et al., 2014; 
Parret et al., 2016).  
Protein translocation. Signal peptides control the rate of protein translocation across 
endoplasmic reticulum and cytoplasmic membranes in eukaryotic and prokaryotic cells 
respectively. The performance of signal peptide parts is typically unpredictable as the design rules 
governing their function are poorly defined (Brockmeier et al., 2006; Haryadi et al., 2015; Obst et 
al., 2017). In particular, features underpinning construct affinity for secretory pathway components, 
such as the signal recognition particle, are not well understood. Moreover, it is not known why 
signal peptide function is highly protein-specific, a phenomenon that is likely determined by amino 
acid sequences at the signal peptide-product N terminal junction. Accordingly, it is not possible to 
rationally select or design signal peptides in order to maximize the translocation rate of specific 
proteins. However, trial and error testing has identified parts that exhibit robust performance with 
diverse protein partners, and panels of these constructs can be screened to find optimal signal 
peptide-product combinations (Güler-Gane et al., 2016; Haryadi et al., 2015; Kober et al., 2013). 
For this example, such screening was unnecessary as previous studies have already identified an 
appropriate signal peptide for the specific context of SEAP production in mammalian cells (Barash 
et al., 2002; Güler-Gane et al., 2016). We therefore included this part (Secrecon) in our component 
palette. Additionally, to test if SEAP translocation rates could be further increased, we applied 
basic information regarding signal peptide sequence features to create four novel synthetic 
constructs. Fundamental signal peptide design principles were determined by analyzing the size, 
structure (i.e. average length of the N-terminal, Hydrophobic, and C-terminal regions) and amino 
acid usage patterns of experimentally verified mammalian sequences. Using these design rules, we 
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created thousands of synthetic parts and tested them in silico using SignalP 4.1, a neural network-
EDVHG DOJRULWKP WKDW TXDQWLILHV WKH ³VLJQDO SHSWLde-QHVV´ '-score) of amino acid sequences 
(Petersen et al., 2011). While some studies have shown no relationship between signal peptide 
prediction scores in silico and functional outputs in vitro (i.e. levels of secreted recombinant 
protein) (Brockmeier et al., 2006), others have found that these properties are positively correlated 
in certain contexts, including SEAP production in HEK293 cells (Barash et al., 2002; Mori et al., 
2015). Accordingly, in an attempt to maximize SEAP secretion efficiency in our system, we graded 
synthetic signal peptides according to their D-score values and selected the four top-ranking parts 
(SSP 1 ± 4; see Fig. S2).   
Cellular biomass capacity. The total cellular capacity available for protein biosynthesis is 
a function of thHFHOOIDFWRU\¶VDELOLW\WRERWKDFFXPXODWHDQGPDLQWDLQELRPDVV$ZLGHUDQJHRI
cell-variants with enhanced biomass capacities have been created for most protein production hosts, 
for example by deriving cell lines/strains with increased proliferation rates (Schlegel et al., 2017; 
Wurm, 2013). However, the biomass performance of a discrete chassis is highly context-specific, 
GHSHQGHQW RQ WKH FHOO¶V PDFURPROHFXODU FRPSRVLWLRQ HJ WUDQVFULSWLRQDO WUDQVODWLRQDO DQG
glycolytic capacities) and the unique metabolic load imposed by each product-expression cassette 
combination (Mahalik et al., 2014; O'Callaghan et al., 2010). These two properties are typically 
poorly defined, and moreover, there is limited understanding of how discrete product biosynthetic 
processes affect biomass output from given host cell backgrounds. Accordingly, it is not currently 
possible to rationally select or design a cell factory in order to maximize biomass capacity in a 
specific biomanufacturing context. We therefore reasoned that multiple candidate-chassis 
combinations will need to be tested to identify a cell host that functions optimally when paired with 
a particular designed expression cassette. In this case, we utilized five functionally-distinct CHO 
cell chassis that were specifically created to exhibit high cellular biomass capacities. Fernandez-
Martell et al. recently utilized a directed evolution approach to generate 22 clonally-derived CHO-
S subclones ZLWKHQKDQFHGVSHFLILFJURZWKUDWHV)HUQDQGH]ဨ0DUWHOOHWDO)RUWKHPDMRULW\
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of these cell lines, an increase in biomass accumulation during exponential phase growth was 
associated with an undesirable decrease in cellular biomass maintenance during stationary phase. 
However, five subclones (ECH1 ± ECH5) were shown to exhibit the optimal combination of rapid 
proliferation and extended maintenance of high cell biomass concentration in multiple 
bioproduction contexts, and, accordingly, we selected these chassis for our component palette.  
Protein folding and secretion. Regardless of the chassis used, if an expression cassette is 
specifically designed to maximize flux through the product biosynthetic pathway, protein folding 
(and secretion where applicable) machinery may become exhausted. Indeed, the capacity for this 
cellular process is commonly found to be limiting in protein biomanufacturing systems (Baeshen 
et al., 2015; Delic et al., 2014; Zhou et al., 2018). Inefficient conversion of unfolded polypeptide 
to final protein product restricts system output, and can adversely affect cell function by inducing 
cellular stress responses (Gasser et al., 2008; Hetz et al., 2015; Hetz & Papa, 2017). These problems 
can be overcome by genetically engineering the cellular protein folding and secretion machinery, 
however, the relative benefits of over-expressing discrete effector genes are context-specific, 
dependent on product folding pathways, chassis macromolecular compositions, and recombinant 
protein expression levels (Delic et al., 2014; Hansen et al., 2017). Accordingly, to identify 
engineering solutions that maximize product folding and secretion rates, a wide range of effectors 
need to be screened in each specific biomanufacturing system. Due to the widespread use of 
synthetic engineering approaches, catalogues of potential candidate genes are available for all 
commonly-used bioproduction host cell-types. Here, we selected twelve components of the protein 
folding and secretion machinery whose overexpression has previously been shown to increase 
product yields in CHO cells, including foldases (Cypb (Johari et al., 2015), Ero1a (Cain et al., 
2013), Pdia1 and Pdia4 (Borth et al., 2005)), chaperones (Bip (Johari et al., 2015), Hspa1a (Y. Y. 
Lee et al., 2009), Tor1a(Jossé et al., 2010), Calr and Canx (J. Y. Chung et al., 2004)), 
transactivators (Atf6ac and Xbp1s (Pybus et al., 2014)) and a lipid transporter (Cert (Florin et al., 
2009)).  
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Identification of context-specific parts that maximize flux through product transcription, 
translation, and translocation.  
To create an expression cassette driving maximal rates of SEAP transcription, translation and 
translocation, we tested the function of our in silico-designed DNA-parts in vitro. We reasoned that 
the component palette screening system needed to be high-throughput, while still maintaining the 
environmental context of industrial scale protein production processes. Accordingly, we utilized a 
relatively rapid (72 h), small scale (24 well plate) screening process where conditions were i) 
optimized to maximize product yields (i.e. DNA load, transfection conditions, cell seeding density) 
and ii) designed to match standard CHO cell biomanufacturing systems as much as possible (i.e. 
growth media, temperature, CO2 atmosphere, cell growth dynamics). To evaluate the performance 
of discrete synthetic expression cassette-chassis combinations, we created a standard reference 
system (SRS; Fig. 2B) comprising components that are either native to the product (SEAP-native 
signal peptide and mature protein coding sequence) or commonly-used in industry (CHO-S cell 
chassis, CMV-,(SURPRWHU¶875RSWLPDONR]DNVHTXHQFH69¶875 
Designed promoters, signal peptides and protein coding sequences were chemically 
synthesized and individually inserted into the SRS, replacing corresponding incumbent parts. As 
shown in Figure 3, synthetic modulation of SEAP transcription, translation and translocation 
enabled significant increases in product yield, where the best-performing constructs increased 
production by 2.05x, 1.38x and 1.48x respectively compared to the SRS. As parts enhanced SEAP 
titer without significantly affecting cell growth (final cell concentrations and culture viabilities 
varied by < 10% compared to the SRS, data not shown) we presumed that productivity gains 
resulted from increased flux through the SEAP biosynthetic pathway. However, we did not 
specifically measure SEAP transcription, translation and translocation levels as we reasoned that i) 
component performance was ultimately characterized by total system output, and, accordingly, ii) 
further system characterization would unnecessarily increase screening time, cost and complexity. 
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Similarly, we did not perform N-terminal sequence analysis to confirm predicted signal peptide 
cleavage sites, although we note that this would be necessary in some contexts, including 
biopharmaceutical manufacturing (Gibson et al., 2017).  
Overall, 11/14 synthetic parts facilitated an increase in SEAP yield, thereby validating our 
component design and selection strategies. The poor performance of the other three constructs may 
have been due to context-specific factors, such as product amino acid sequence. For example, while 
the expression level of certain proteins can be increased by minimizing mRNA secondary structures 
(Kim et al., 2010), application of this design method to the SEAP coding sequence (SEAP_MSS) 
resulted in near-complete abrogation of protein production (Fig. 3C). Although this unpredictability 
in part performance necessitates screening multiple constructs to identify those that exhibit desired 
functionality in discrete biomanufacturing contexts, we have shown here that this can be achieved 
XVLQJ D PLQLPDO FRPSRQHQW SDOHWWH   FRQVWUXFWV SHU SDUW W\SH 0RUHRYHU SDUW GHVLJQ DQG
selection methods will further improve with multiple iterations of the design-build-test-learn 
process.  
To increase the rate of multiple product biosynthetic processes simultaneously, we created 
expression cassettes containing combinations of the best performing synthetic components. As 
shown in Figure 3D, concurrent enhancement of SEAP transcription, translation and translocation 
enabled significantly higher titers than systems where only one or two of these rates were 
optimized. The ideal combination of promoter, protein coding sequence and signal peptide 
increased SEAP yield by 302% compared to the SRS, thereby highlighting the potential benefits 
of designing these three part-types in unison. However, while simultaneously increasing the flux 
through product transcription, translation and translocation should, in theory, synergistically 
increase system output, incorporating best performing parts into an optimal expression cassette 
only had an additive effect on SEAP titer. This may have been due to functional redundancy 
between SSP2 and SEAP_MO as signal peptide coding sequences can affect mRNA translation 
rates, particularly at the level of initiation. However, utilizing these two parts together without 
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100RPU_PH (i.e. used in conjunction with the standard hCMV-IE1 promoter) had a synergistic 
effect on SEAP production, indicating that SSP2 predominantly functioned by increasing protein 
translocation. 100RPU_PH: SSP2 and 100RPU_PH: SEAP_MO combinations also synergystically 
increased system output, suggesting that discrete component performances were not significantly 
affected by physical context (e.g. sequences at part junctions). These data show that when any two 
rates were increased, product yields were within -12% of that expected if effects were 
multiplicative, compared to a -28% difference when all three were enhanced. We therefore 
reasoned that i) the metabolic load imposed on the host cell by concurrent maximization of product 
transcription, translation and translocation rates created a bottleneck in the recombinant protein 
synthetic pathway, most likely in protein folding and secretion, and ii) as a result, we had reached 
the maximum production gains that were possible via DNA-part design. To confirm this, we created 
an expression cassette containing the second-best performing construct for each component-type 
(100RPU.1, Secrecon, SEAP_CAI). As shown in Figure 3D, using this promoter-signal peptide-
protein coding sequence combination resulted in the same level of system output as 100RPU_PH: 
SSP2: SEAP_MO. Accordingly, we determined that further increases in SEAP yield would require 
improvements in CHO cell chassis performance.  
 
Selection and engineering of a chassis to maximize both cellular biomass capacity and cell-
specific productivity. 
Having identified DNA parts that maximize flux through the SEAP biosynthetic pathway, we next 
sought to derive a chassis that was specifically optimized to function in conjunction with them. To 
achieve this, we first tested the optimized expression cassette in combination with our panel of five 
CHO cell lines that have previously been shown to display desirable biomass phenotypes.  
Utilization of ECH1, ECH2, or ECH4 significantly enhanced SEAP yield, where the best 
performing cell line (ECH2) increased production 1.9x compared to the standard CHO-S cell 
factory (Fig. 4A). Production gains were approximately proportional to increases in total cellular 
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capacity (measured as the integral of viable cell concentration), indicating that these chassis were 
able to exhibit improved rates of biomass accumulation and maintenance without suffering an 
associated decrease in cell-specific productivity. Indeed, the level of SEAP production per cell was 
slightly increased in ECH1 and ECH2.  
To determine the effect of using cell capacity enhancement as a stand-alone approach for 
improving SEAP titer, we tested each chassis in concert with the standard reference expression 
cassette. This analysis showed that i) ECH2 facilitated a 2.2x increase in product yield relative to 
the SRS, and ii) the rank order of chassis performance was the same when using either combination 
of DNA parts (see Fig. S3). Given the latter, we concluded that relative differences in SEAP 
production between distinct cell chassis were not a result of varying output from discrete genetic 
components. Indeed, while altering the chassis carries a risk of significantly affecting part 
functionalities, we assume that this is relatively minor given that it would require substantial 
changes in the activity of specific transcriptional, translational or translocational machinery 
components (e.g. distinct transcription factors or tRNAs). We postulated that the high cellular 
capacity/low SEAP production phenotype displayed by ECH3 and ECH5 may have been a function 
of unequal resource allocation, whereby these chassis produced cellular biomass at the expense of 
SEAP biosynthesis. The poor performance of these cell factories, which could also have been due 
to product or process specific factors, highlights the requirement to test a panel of chassis in each 
unique biomanufacturing context. However, as demonstrated here, if cell lines are rationally 
selected based on well-characterized phenotypes, a chassis with desired functionality can be 
identified from a relatively small number of candidates.  
Finally, we attempted to enhance SEAP production-per-FHOO E\ LQFUHDVLQJ WKH FKDVVLV¶
capacity for protein folding and secretion. The twelve candidate genetic effectors were each 
transfected into ECH2 alongside the optimized 100RPU_PH: SSP2: SEAP_MO expression 
cassette. Given that genetic engineering outcomes are dependent on effector expression levels, 
where gene dosages need to be carefully tailored to achieve desired phenotypes without negatively 
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affecting other important cellular functions (Johari et al., 2015; Pybus et al., 2014; Tastanova et al., 
2016), we tested each component at three different concentrations. To ensure a fair comparison 
between the control (i.e. SEAP reporter plasmid transfected in isolation) and genetically engineered 
systems, we i) kept DNA load constant across all transfections in order to maintain optimized 
experimental conditions, and ii) did not use empty vector to normalize SEAP reporter plasmid copy 
numbers (i.e. to prevent artificially hampering control system performance). No significant 
improvements in SEAP yield were observed when effector genes were used at a 1:40 or 1:20 molar 
ratio relative to the product gene (data not shown). However, product titer increased 1.39-fold 
compared to the control system when Atf6ac and Seap were co-transfected at a 1:10 ratio (Fig. 4B). 
Subsequent testing of this effector over an extended concentration range identified that SEAP yield 
was maximized (161% increase over control) by using an Atf6ac: Seap ratio of 1: 6.66, where 
increased production was a result of enhanced cell specific productivity (i.e. cellular biomass 
capacity was unaffected; Fig. 4C).  
ATF6A is a TF that upregulates expression of protein folding machinery components, such 
as foldases and chaperones, under conditions of ER stress (Brewer, 2014). Expression of a 
constitutively active version (ATF6Ac) of this effector forces cells to increase their protein folding 
capacity. Accordingly, we reasoned that ATF6Ac enhanced SEAP titer by alleviating a bottleneck 
in product folding. Unsurprisingly, ATF6Ac (nor any other effector) had no effect on SEAP 
production when used in conjunction with the standard reference expression cassette (data not 
shown), as the level of product expression driven by this construct (i.e > 3-fold lower than the 
RSWLPL]HGH[SUHVVLRQFDVVHWWHZDVDOUHDG\HIILFLHQWO\KDQGOHGE\WKHFKDVVLV¶H[LVWLQJ(5FDSDFLW\
(Hansen et al., 2017). We therefore concluded that i) maximizing SEAP transcription, translation, 
and translocation resulted in an excess of unfolded polypeptide, but this load was not sufficient to 
induce substantial ER stress, and ii) triggering an artificial unfolded protein response (UPR) 
facilitated conversion of this material to finished product, thereby increasing SEAP yield. While 
the other eleven components had no effect on SEAP production, overexpression of discrete 
20 
 
chaperones/foldases, and activation of alternative UPR arms, have been shown to be beneficial in 
other settings (Baeshen et al., 2015; Delic et al., 2014; Fischer et al., 2015). Although unpredictable 
context-dependent factors (e.g. product-type, process conditions) prevent rational or generic 
engineering of protein folding machineries to improve product titers, as shown here, an optimal, 
system-specific solution can be determined by screening a wide variety of diverse genetic effectors. 
The final optimized chassis-expression cassette combination increased SEAP yield by 
924% compared to the SRS. As summarized in Figure 5, synthetic modification of the entire 
product biosynthetic pathway facilitated substantially greater SEAP titers than engineering the cell, 
vector, or discrete process steps in isolation. These results therefore validate our design strategy to 
use minimal palettes of synthetic components (just 31 in this example) to derive optimal protein 
biomanufacturing systems by simultaneously maximizing both cellular capacity and product 
biosynthetic flux.  To confirm that the system assembled via small-scale, high-throughput screening 
maintained its functionality in more industrial-like production contexts, we evaluated its 
performance in a 6-day fed-batch process in mini-bioreactors. This analysis showed that the 
optimized system achieved a similarly high increase in SEAP production (12.37-fold) relative to 
the SRS in this new environmental context. While we assume that synthetic chassis-expression 
cassette combinations will also maintain their functionalities in stable expression platforms, we did 
not definitively prove this by creating and testing clonal cell lines. Indeed, we reasoned that this 
time-consuming process, typically employed to enhance product expression in mammalian 
systems, may be unnecessary if transient production yields can be increased by an order of 
magnitude (although we note that for biopharmaceutical manufacturing this would require 
regulatory approval of transient expression approaches). 
  
Concluding remarks 
The design process that we have presented here for creating optimal expression cassette-chassis 
combinations should be applicable to diverse bioproduction contexts. Given the universality of the 
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core product biosynthetic pathway, the design-test-build methodology described could be used in 
conjunction with a wide range of commonly-utilized biomanufacturing host cell-types. However, 
larger component palettes may be required for more complex protein structures, including common 
therapeutic product-types such as multi-VXEXQLWSURWHLQVHJPRQRFORQDODQWLERGLHVDQG³GLIILFXOW
WRH[SUHVV´QRQ-natural, engineered protein formats (e.g. fusion proteins). For these products, it 
will likely be beneficial to use genetic components with more diverse quantitative outputs (e.g. a 
wide range of transcriptional activities) in order to enable identification of optimal, protein-specific 
ratios of biosynthetic process rates and/or polypeptide chain expression levels.  
System outputs may be further increased by including additional part-types in component-
design palettes. For example, non-coding RNAs and chemical effectors can be rationally selected 
to enhance cellular biomass capacity and/or recombinant protein production per cell (Allen et al., 
2008; Fischer et al., 2014). Further, for some products it will be beneficial to employ genetic 
effectors of additional cellular processes. Indeed, while we have focussed on maximizing 
recombinant protein yield, product quality can be significantly enhanced via glycosylation 
engineering (Costa et al., 2014; Wang et al., 2018). Accordingly, where glycosylation profiles are 
known determinants of key product attributes, such as bioactivity or serum half-life, appropriate 
genetic effectors could be utilized (i.e. in conjunction with an expression cassette-chassis 
combination that maximizes product titer) to achieve desirable, user-defined glyco-modifications. 
Moreover, while we determined suitable effector gene dosages from a limited range of discrete 
concentration points, system performance may be optimized by using auto-regulatory feedback 
loops to precisely fine-tune effector expression levels. For example, UPR stress-responsive 
promoters could be employed to dynamically coordinate production of protein folding machinery 
components with ER capacity limitations (Ruijter et al., 2016). Finally, where HT robotic screening 
systems are available, optimal synthetic part-assemblies may be identified more rapidly by 
exploring the entire component-combination design space in a single experiment. By 
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simultaneously testing 1000s of promoter-signal peptide-protein coding sequence-chassis-genetic 
effector compositions, ideal biomanufacturing systems could be derived in a matter of weeks. 
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Figure legends 
Figure 1: Recombinant protein production system output is determined by synthetically 
engineerable input components. Product yields are a function of five key biosynthetic process rates, 
each of which can be modified by designing either the chassis or discrete genetic parts. UTR = 
untranslated region; RBS = ribosome binding site; CDS =  coding sequence. 
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Figure 2: A minimal synthetic component-palette for maximizing SEAP production in CHO cells. 
Synthetic components were rationally designed and selected to enable derivation of a biomanufacturing 
system in which both cellular capacity and product biosynthetic flux are maximized (A). A system 
comprising commonly-utilized, and native, product-specific components was used as a reference 
standard for evaluating the performance of discrete synthetic expression cassette-chassis combinations 
(B). UTR = untranslated region; RBS =  ribosome binding site; CDS =  coding sequence; PKS =  perfect 
Kozak sequence. 
 
Figure 3: Assembling an expression cassette that maximizes flux through SEAP transcription, 
translation and translocation. Designed (D) parts were synthesized and individually inserted into a 
system comprising standard reference (SR) components (see Figure 2). The function of synthetic 
promoters (panel A), signal peptides (panel B) and SEAP coding sequences (panel C) was evaluated in 
a 72 hr transient production process, and best-performing parts were subsequently used in combination 
(panel D). Data are expressed as a percentage of the production exhibited by the standard reference 
system; statistically significant differences are indicated by asterisks (one-way ANOVA followed by 
'XQQHWW¶V WHVW: *P < 0.05, **P < 0.01, ***P < 0.001). Values represent the mean ± SD of three 
independent experiments (n = 3, each performed in triplicate). 
 
Figure 4: Selecting and engineering a chassis to maximize cellular biomass capacity and cell-
specific productivity. A SEAP reporter vector containing an optimal combination of synthetic genetic 
components (shown at the top of the panel; see Figure 3D) was transiently transfected into varying CHO 
cell chassis (A). Cell growth was measured at 24 h intervals to calculate integral viable cell 
concentration (IVCC) values. SEAP production was quantified 72 h post-transfection, and cell-specific 
productivities (qP) were determined. Data are expressed as a percentage of the production achieved 
using a standard CHO-S cell line; statistically significant differences are indicated by asterisks (one-
ZD\$129$IROORZHGE\'XQQHWW¶VWHVW: *P < 0.05, **P < 0.01, ***P < 0.001). The optimized SEAP-
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reporter vector was then co-transfected into the best-performing chassis (ECH2) alongside either B) 
varying effector gene expression plasmids at a molar ratio of 10: 1, or C) an ATF6Ac expression 
plasmid at varying molar ratios. Data are expressed as a percentage of the production achieved when 
the SEAP reporter plasmid was used in isolation; statistically significant differences are indicated by 
asterisks (one-ZD\$129$IROORZHGE\'XQQHWW¶VWHVW: *P < 0.05, **P < 0.01, ***P < 0.001). The 
total amount of transfected DNA was kept constant in all cases (empty vector was not used to normalize 
SEAP-reporter plasmid copy numbers). In A, B, and C, values represent the mean ± SD of two, two, 
and three independent experiments respectively (n = 2, 2, 3, each performed in triplicate). 
 
Figure 5: The performance of an optimally designed synthetic expression cassette-chassis 
combination is maintained in a scaled-up, fed-batch production process. A) Summary of the effect 
discrete system engineering strategies had on SEAP yield in the context of a 72 h production process in 
24-well plates. B) A SEAP reporter vector containing an optimal combination of synthetic genetic 
components, and an ATF6Ac expression plasmid, were co-transfected into ECH2 CHO cells at a molar 
ratio of 6.66: 1 (system comSRVLWLRQ µDOOFRPSRQHQWVRSWLPL]HG¶ SEAP production was measured 
over the course of a 6-day fed-batch process in tube-spin bioreactors. Data are expressed as a percentage 
of the production exhibited by the standard reference system (see Figure 2). Values represent the mean 
± SD of two independent experiments (n = 2, each performed in duplicate). 
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